Memphasys (ASX:MEM) Presentation, FNN Investor Event, November 2019, Melbourne

Company Presentations

Memphasys Limited (ASX:MEM) Executive Chairman Alison Coutts presents on progress with the company's human assisted reproductive device for the separation of sperm cells in IVF clinics at FNN's Investor Event.

Key points:

  • Bio-separations company specialising in innovative separation techniques
  • Based on the company's proprietary membrane technology
  • Separation of the "best" sperm for use in human in vitro fertilisation (IVF)
  • Poor sperm quality a factor in approximately 50% of infertility cases
  • IVF market anticipated to grow US$13.7b in 2019 to US$26b by 2026
  • Backed by industry experts and leaders in the field

For more, watch Executive Chairman Alison Coutts present.